<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "indomethacin supp">
<dose><value>100</value>
<value>50</value>
</dose><route><value>PR</value>
</route><form><value>supp</value>
</form><drugname><value>indomethacin supp</value>
</drugname><strength><value>100 mg</value>
<value>50 mg</value>
</strength><frequency><value>HS</value>
<value>BID</value>
<value>TID</value>
</frequency><instruction></instruction><volume></volume><units><value>mg</value>
</units><additionalnotes><value>Patients identified as carriers of Hepatitis B virus should be monitored for signs/symptoms of relapse of HBV infection throughout therapy and several months following termination of therapy.</value>
</additionalnotes><population></population><indicationprn></indicationprn><backgroundinformation></backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Analgesics and Antipyretics, Nonsteroidal Anti-inflammatory Agents</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>01934139</value>
<value>02231700</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>